L3Harris Technologies Operating Cash Flow decreased by 126.2% to -$95.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 126.2%, from -$42.00M to -$95.00M. Over 3 years (FY 2021 to FY 2024), Operating Cash Flow shows relatively stable performance with a -1.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $661.00M | $127.00M | $588.00M | $1.31B | $39.00M | $725.00M | $543.00M | $851.00M | $350.00M | $300.00M | $780.00M | $666.00M | -$104.00M | $702.00M | $546.00M | $1.42B | -$42.00M | -$95.00M |
| QoQ Change | — | -80.8% | +363.0% | +123.0% | -97.0% | >999% | -25.1% | +56.7% | -58.9% | -14.3% | +160.0% | -14.6% | -115.6% | +775.0% | -22.2% | +159.2% | -103.0% | -126.2% |
| YoY Change | — | — | — | — | -94.1% | +470.9% | -7.7% | -35.1% | +797.4% | -58.6% | +43.6% | -21.7% | -129.7% | +134.0% | -30.0% | +112.5% | +59.6% | -126.2% |